featured
Metastasis-Free Survival is Associated With Overall Survival in Men With PSA-Recurrent Prostate Cancer Treated With Deferred Androgen Deprivation Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Metastasis-Free Survival is Associated With Overall Survival in Men With PSA-Recurrent Prostate Cancer Treated With Deferred Androgen Deprivation Therapy
Ann. Oncol 2013 Aug 14;[EPub Ahead of Print], MT Schweizer, XC Zhou, H Wang, T Yang, F Shaukat, AW Partin, MA Eisenberger, ES AntonarakisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.